NCT00424424终止2 期
Proprietary Information - Exploratory (Non-Confirmatory) Trial
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 入组人数
- 81
- 主要终点
- Proprietary Information - Exploratory (Non-Confirmatory) Trial
研究概览
简要总结
This study is being conducted to evaluate the safety and tolerability of the drug and to evaluate its efficacy compared to placebo and to ibuprofen in the prevention of postoperative dental pain in male patients.
This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time. (Full information is available to trial participants).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 45 Years(Adult)
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Patients in generally good health who are scheduled to have 2 or more third molars removed, at least 1 of which is partially or completely embedded in bone and is a mandibular impaction
排除标准
- •Patient has a history of any illness or condition that, in the opinion of the investigator, might confound the results of the study or pose additional risk to the patient
结局指标
主要结局
Proprietary Information - Exploratory (Non-Confirmatory) Trial
次要结局
- Proprietary Information - Exploratory (Non-Confirmatory) Trial
研究者
相似试验
招募中
1 期
An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid TumoursSolid CancerNCT06697665Suzhou BlueHorse Therapeutics Co., Ltd.10
尚未招募
早期 1 期
A Clinical Study on LM103 Injection for the Treatment of Advanced Solid TumorsSolid TumorNCT05971589Suzhou BlueHorse Therapeutics Co., Ltd.5
招募中
早期 1 期
A Clinical Study on LM103 for the Treatment of Advanced Solid TumorsSolid TumorNCT05941936Suzhou BlueHorse Therapeutics Co., Ltd.5
尚未招募
早期 1 期
A Clinical Study on TILs for the Treatment of Advanced Solid TumorsSolid TumorNCT05971576Suzhou BlueHorse Therapeutics Co., Ltd.20
已完成
不适用
A Clinical Study to Assess the Effect of Increasing Intake Amounts of Two Novel Glycans on the Gut Microbiota of Healthy SubjectsHealthyNCT04619875Kaleido Biosciences36
